Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Ehud Marom
CEO | Chief Executive Officer | 73 | 01.01.08 |
Nir Bernstein
DFI | Director of Finance/CFO | 57 | 01.11.13 |
Laura Popper
CTO | Chief Tech/Sci/R&D Officer | - | - |
Shai Rubnov
CTO | Chief Tech/Sci/R&D Officer | 51 | 01.01.09 |
Alex Mogle
BRD | Director/Board Member | 56 | 01.06.12 |
Nadav Kimelman
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Dov Pekelman
BRD | Director/Board Member | 84 | - |
Ehud Marom
CEO | Chief Executive Officer | 73 | 01.01.08 |
Itamar Borowitz
BRD | Director/Board Member | 80 | 01.05.09 |
Alex Mogle
BRD | Director/Board Member | 56 | 01.06.12 |
Itay Attar
BRD | Director/Board Member | - | - |
Uri Yaron
BRD | Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 11 761 362 | 0 | 0 | - |
Unternehmenskontakt
Mapi-Pharma Ltd.
16 Einstein Street Weizmann Science Park
74140, Ness Ziona
+972 7 3712 1213
http://www.mapi-pharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+15,20 % | 121 Mrd. | |
+19,67 % | 113 Mrd. | |
+18,95 % | 26,02 Mrd. | |
-23,86 % | 19,39 Mrd. | |
-19,03 % | 15,91 Mrd. | |
-20,90 % | 15,09 Mrd. | |
-46,14 % | 15,06 Mrd. | |
+63,85 % | 14,93 Mrd. | |
+4,49 % | 13,85 Mrd. |